Skip to Main Content
Banner: Lunch and Learn Provider Education Series

Syphilis Update 2022: What's going on here??

Syphilis is an endemic public health problem that affects infants, children and adults. Syphilis diagnoses continue to increase nationwide and in Louisiana, which has historically had high rates of syphilis infection. To combat the resurgence of syphilis and improve the health of our patients and community, healthcare providers need to understand the symptoms, impact, diagnosis and treatment of syphilis.

 

At the conclusion of this presentation, the learner will be able to:

 

  1. recognize the signs and symptoms of syphilis in infants and adults
  2. determine the appropriate testing strategy for diagnosis of syphilis
  3. initiate prompt treatment of syphilis based on the stage of disease
  4. report syphilis diagnoses to appropriate public health agencies for contact tracing.

Thursday, October 26, 2022, @ Noon

Speakers: 

John Vanchiere, MD

This training is eligible for CME credit.

Registration Link: https://centene.zoom.us/webinar/register/WN_E6Eoct1jQgioXf-6X-jcJw

 

 

The Louisiana AAP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Louisiana AAP is accredited by the Texas Medical Association to provide continuing medical education for physicians. 

John Vanchiere has disclosed that he administers clinical trial contracts with Pfizer, Merck, Enanta, and Biocryst and consults for Syneos and Seqirus. Louisiana AAP planning committee member, Joseph Bocchini, Jr., MD, has disclosed that he has received research grant funds from Regeneron and Novavax and sits on the Advisory Board for Pfizer and Dynavax.  All remaining faculty, Louisiana AAP Education Committee members and staff have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships have been mitigated.

Lunch and LEARN Series: ASAM criteria: differentiating between ASAM 3.5 and 3.7c 

Lunch and LEARN Series: Fluoride Vanish and Pedicatric Oral Health

Lunch and LEARN Series: Vaccines for Children: Addressing Parental Hesitency

Lunch and Learn Series: Flipping the Script on Person-Centered Care

Lunch and LEARN Series: COVID Vaccines for Children: Tools for curbing the ever-evolving pandemic!

Lunch and Learn Series: Hepatitis C Evaluation and Treatment Update

Lunch and LEARN Series: Improving Outcomes in Your Patients with Diabetes

Lunch and Learn Series: Colorectal Cancer Screening in Primary Care

Lunch and LEARN Series: Saving the Lives of Louisiana's Women Through Cervical Cancer Screening

Lunch and LEARN Series: HIV in Louisiana Primary Care

Lunch and LEARN Series: What, Why and What's Next: The Importance of NTSV

Lunch and LEARN Series: Blood Pressure Management